Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Why the underestimated economic burden of rare diseases could be costing the U.S. trillions of dollars

While rare diseases impact a small population, the cost to society is staggering. It may be in the range of $7.2-$8.6 trillion per year.

Fortune

A psychedelic clue to the cause of SIDS

A new study using radioactive psychedelics suggests that infants who die of SIDS have abnormal serotonin receptors

Salon

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

U.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Warning flesh-eating zombie drug could be widespread in UK after first death

It has contributed to an epidemic of drug deaths in the US

Wales Online

There’s Still Scary Stuff in Sunscreen

Endocrine disrupters and other potentially dangerous ingredients persist despite FDA concerns.

Businessweek

Analysts expect Medtronic to deliver frank financial answers this week

Medtronic is facing sluggish sales growth, is in the midst of deep cost-cutting and started ongoing global layoffs in April. It's also spinning off businesses with weaker profit margins.

Tribune News Service

If Sen. John Cornyn is part of the ‘deep state,’ as Trump says, what exactly is the deep state?

WASHINGTON – Sen. John Cornyn earned a spot on Donald Trump’s naughty list by saying the GOP should pick someone else for president in 2024.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Extremely rare case of mad cow disease detected in the US

It is only the seventh case of the deadly disease reported in the U.S. since it first emerged in the country in 2003.

LiveScience

4 Hyper-Growth Stocks That Could Soar

Coupled with the macroeconomic headwinds, the U.S. debt default crisis and consequent recessionary fears have triggered market volatility. Against this backdrop, quality growth stocks Boston Scientific (BSX), Cardinal Health (CAH), Cidara Therapeutics (CDTX), and Geospace Technologies (GEOS) could be solid buys now. Read on….

StockNews.com

First Brit to die of flesh-eating 'zombie drug' named as dad-of-two

Karl Warburton, 43, died last May from xylazine, which is used by vets as a tranquilliser for large animals such as horses and cows - the drug has never been approved for human use as it can cause flesh-rotting sores on takers’ skin

Daily Mirror

‘Zombie drug’ could be widespread in UK, experts warn

Xylazine is a powerful sedative which has swept across the United States.

The Independent UK

Brit man, 43, dies after taking notorious US 'zombie drug' in grim new UK first

A British man has become the first confirmed to have died after taking powerful drug Xylazine, dubbed the zombie drug, in the UK after dozens across the United States

Daily Mirror

GOP moves to limit abortion pill in US

A House panel advanced a 2024 budget bill that would block the ability to access the abortion drug via telehealth

Salon

This tech CEO is swapping blood with his 17-year-old son to stay young

This CEO is going to against the better judgment of the FDA to remain youthful.

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Lisa Jarvis: How to solve America’s drug shortage problem

Drug shortages in the US are forcing physicians and the public to scramble for access to vital medicines. While the problem isn’t new, the number of products in scarce supply is nearing an all-time high — and could get worse as generic drug makers pare back on the breadth of…

WEKU

A new nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval

The Independent UK

New nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval

U.S. health regulators have approved a new nasal spray to reverse overdoses due to fentanyl and other powerful opioids

LiveScience

New gene therapy gel is the 1st approved treatment for rare and painful 'butterfly disease'

The U.S. Food and Drug Administration approved a gene therapy for dystrophic epidermolysis bullosa, also known as butterfly disease.

Get all your
news in one place.

100's of premium titles.
One news app.

Daily Mirror

Four die from rare strain of bacteria that can 'melt' through eyeballs

The Centres for Disease Control and Prevention (CDC) confirmed the number of patients treated for the drug-resistant strain of Pseudomonas aeruginosa has now risen to 81 patients in 18 states

The Independent UK

What is fezolinetant? The non-hormonal menopause treatment drug explained

The FDA-licensed drug could be approved for use in the UK by the end of the year

Chicago Sun-Times

More dogs welcomed in outdoor dining spaces, but not everyone is happy

The FDA’s updated food code, restaurants should have signs saying dogs are welcome and should develop plans to handle dogs and their waste. They should provide separate food bowls so dogs don’t use plates or utensils meant for humans.

Axios

Medical AI's weaponization

Intentionally deadly bugs and toxins and misinformation are some key fears.

WEKU

With growing abortion restrictions, Democrats push for over-the-counter birth control

With abortion increasingly restricted in many states, Sen. Patty Murray (D-Wash.), hopes to persuade Republicans to back insurance coverage for over-the-counter birth control.

Chicago Tribune

Commentary: By avoiding funding Alzheimer’s research, the government is cutting seniors’ life spans

Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration could approve the new treatment, donanemab, as soon as this year.

The Guardian - UK

The Crown Prosecution Service isn’t ‘cherrypicking’. It’s making the right calls

Letters: In all the domestic abuse cases where the CPS took no further action, it had made the right decision, says chief inspector Andrew T Cayley, while Duncan Woodhead of the FDA union also rejects claims of ‘cherrypicking’

1 … 159 160 161 162

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Crown Prosecution Service

406 stories

the Food and Drug Administration

222 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.